INTRODUCTION: This study aims to observe the health-related quality of life and depression and anxiety symptoms of newly diagnosed patients who were taking four-drug anti-tuberculosis (anti-TB) therapy during the treatment period.
METHODS: The TB-diagnosed patients who were taking four-drug TB therapy and suitable for this study were followed up during the treatment period in the providence of Eskişehir. The patients were assessed according to the Short From-36 (SF-36) health quality, Beck depression, and Beck anxiety scales at three months and at the end of this study (six months).
RESULTS: Significant improvements were observed in all SF-36 components at the end of this study (p< 0.001). When compared with the beginning and the end of the treatment, there was a statistically significant decrease in Beck depression and anxiety scores (p<0.001).
DISCUSSION AND CONCLUSION: Improvement in the patients Beck depressionanxiety and life quality scores without additional psychiatric treatment is an important finding. These scientific outcomes show that, like other chronic diseases, TB may cause psychiatric problems.